相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model
Rachel Underwood et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
Analysis of Interactions Stabilized by Fusicoccin A Reveals an Expanded Suite of Potential 14-3-3 Binding Partners
Ananya Sengupta et al.
ACS CHEMICAL BIOLOGY (2020)
Identification of Phosphate-Containing Compounds as New Inhibitors of 14-3-3/c-Abl Protein-Protein Interaction
Leire Iralde-Lorente et al.
ACS CHEMICAL BIOLOGY (2020)
Targeting Strategies for Tissue-Specific Drug Delivery
Zongmin Zhao et al.
CELL (2020)
Selectivity via Cooperativity: Preferential Stabilization of the p65/14-3-3 Interaction with Semisynthetic Natural Products
Madita Wolter et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Probing the 14-3-3 Isoform-Specificity Profile of Protein Protein Interactions Stabilized by Fusicoccin A
Ananya Sengupta et al.
ACS OMEGA (2020)
Experimental and Computational Druggability Exploration of the 14-3-3ζ/SOS1pS1161 PPI Interface
Alice Ballone et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Polypharmacological Perturbation of the 14-3-3 Adaptor Protein Interactome Stimulates Neurite Outgrowth
Andrew Kaplan et al.
CELL CHEMICAL BIOLOGY (2020)
2020 Alzheimer's disease facts and figures
[Anonymous]
ALZHEIMERS & DEMENTIA (2020)
Chemically stable inhibitors of 14-3-3 protein-protein interactions derived from BV02
Leire Iralde-Lorente et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Site-Directed Fragment-Based Screening for the Discovery of Protein-Protein Interaction Stabilizers
Eline Sijbesma et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
14-3-3 Proteins Are on the Crossroads of Cancer, Aging, and Age-Related Neurodegenerative Disease
Xiaolan Fan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cooperativity basis for small-molecule stabilization of protein-protein interactions
Pim J. de Vink et al.
CHEMICAL SCIENCE (2019)
Modulators of 14-3-3 Protein-Protein Interactions
Loes M. Stevers et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Inhibition of 14-3-3/Tau by Hybrid Small-Molecule Peptides Operating via Two Different Binding Modes
Sebastian A. Andrei et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Rationally Designed Semisynthetic Natural Product Analogues for Stabilization of 14-3-3 Protein-Protein Interactions
Sebastian A. Andrei et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Semisynthesis and biological evaluation of a cotylenin A mimic derived from fusicoccin A
Takatsugu Inoue et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein-protein interactions
K. L. Pennington et al.
ONCOGENE (2018)
14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein
Bing Wang et al.
JOURNAL OF NEUROSCIENCE (2018)
14-3-3 epsilon a directs the pulsatile transport of basal factors toward the apical domain for lumen growth in tubulogenesis
Yuji Mizotani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
LRRK2 activation in idiopathic Parkinson's disease
Roberto Di Maio et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
14-3-3 proteins activate Pseudomonas exotoxins-S and -T by chaperoning a hydrophobic surface
Tobias Karlberg et al.
NATURE COMMUNICATIONS (2018)
A Thermodynamic Model for Multivalency in 14-3-3 Protein-Protein Interactions
Loes M. Stevers et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Small-Molecule Stabilization of 14-3-3 Protein-Protein Interactions Stimulates Axon Regeneration
Andrew Kaplan et al.
NEURON (2017)
PAK6 Phosphorylates 14-3-3γ to Regulate Steady State Phosphorylation of LRRK2
Laura Civiero et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Dysregulation of 14-3-3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology
Michael B. McFerrin et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2017)
Identification of Two Secondary Ligand Binding Sites in 14-3-3 Proteins Using Fragment Screening
Eline Sijhesma et al.
BIOCHEMISTRY (2017)
Small-Molecule Stabilization of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) Interface
David Bier et al.
CHEMMEDCHEM (2016)
Ablation of the 14-3-3gamma Protein Results in Neuronal Migration Delay and Morphological Defects in the Developing Cerebral Cortex
Tomoka Wachi et al.
DEVELOPMENTAL NEUROBIOLOGY (2016)
14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening
Nicholas J. Lavalley et al.
HUMAN MOLECULAR GENETICS (2016)
From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery
William A. Banks
NATURE REVIEWS DRUG DISCOVERY (2016)
Origin of a folded repeat protein from an intrinsically disordered ancestor
Hongbo Zhu et al.
ELIFE (2016)
Stabilizer-Guided Inhibition of Protein-Protein Interactions
Lech-Gustav Milroy et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
14-3-3-Pred: improved methods to predict 14-3-3-binding phosphopeptides
Fabio Madeira et al.
BIOINFORMATICS (2015)
Inhibition of 14-3-3 Proteins Leads to Schizophrenia-Related Behavioral Phenotypes and Synaptic Defects in Mice
Molly Foote et al.
BIOLOGICAL PSYCHIATRY (2015)
Involvement of 14-3-3 in tubulin instability and impaired axon development is mediated by Tau
Yuyoung Joo et al.
FASEB JOURNAL (2015)
14-3-3 INHIBITION PROMOTES DOPAMINERGIC NEURON LOSS AND 14-3-3θ OVEREXPRESSION PROMOTES RECOVERY IN THE MPTP MOUSE MODEL OF PARKINSON'S DISEASE
H. Ding et al.
NEUROSCIENCE (2015)
14-3-3ζ deficient mice in the BALB/c background display behavioural and anatomical defects associated with neurodevelopmental disorders
Xiangjun Xu et al.
SCIENTIFIC REPORTS (2015)
Constrained Peptides with Target-Adapted Cross-Links as Inhibitors of a Pathogenic Protein-Protein Interaction**
Adrian Glas et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
The chaperone-like protein 14-3-3η interacts with human α-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing α-synuclein cellular toxicity
Nicoletta Plotegher et al.
HUMAN MOLECULAR GENETICS (2014)
The Phytotoxin Fusicoccin Differently Regulates 14-3-3 Proteins Association to Mode III Targets
Alessandro Paiardini et al.
IUBMB LIFE (2014)
14-3-3ε and ζ Regulate Neurogenesis and Differentiation of Neuronal Progenitor Cells in the Developing Brain
Kazuhito Toyo-oka et al.
JOURNAL OF NEUROSCIENCE (2014)
14-3-3 Proteins Are Required for Hippocampal Long-Term Potentiation and Associative Learning and Memory
Haifa Qiao et al.
JOURNAL OF NEUROSCIENCE (2014)
Parkinson-related LRRK2 mutation R1441C/G/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3
Kathrin Muda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Ultrasensitivity part II: multisite phosphorylation, stoichiometric inhibitors, and positive feedback
James E. Ferrell et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
ANIA: ANnotation and Integrated Analysis of the 14-3-3 interactome
Michele Tinti et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2014)
Interaction of 14-3-3ζ with Microtubule-Associated Protein Tau within Alzheimer's Disease Neurofibrillary Tangles
Hamid Y. Qureshi et al.
BIOCHEMISTRY (2013)
A Semisynthetic Fusicoccane Stabilizes a Protein-Protein Interaction and Enhances the Expression of K+ Channels at the Cell Surface
Carolin Anders et al.
CHEMISTRY & BIOLOGY (2013)
Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors
F. U. Woehrle et al.
LEUKEMIA (2013)
Advances in the genetics of Parkinson disease
Joanne Trinh et al.
NATURE REVIEWS NEUROLOGY (2013)
Multivalency as a Chemical Organization and Action Principle
Carlo Fasting et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
A Novel Fusicoccin Derivative Preferentially Targets Hypoxic Tumor Cells and Inhibits Tumor Growth in Xenografts
Koshi Kawakami et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2012)
Structural Biology and Drug Discovery of Difficult Targets: The Limits of Ligandability
Sachin Surade et al.
CHEMISTRY & BIOLOGY (2012)
An Optimised Small-Molecule Stabiliser of the 14-3-3-PMA2 Protein-Protein Interaction
Anja Richter et al.
CHEMISTRY-A EUROPEAN JOURNAL (2012)
Neurodevelopmental and neuropsychiatric behaviour defects arise from 14-3-3ζ deficiency
P-S Cheah et al.
MOLECULAR PSYCHIATRY (2012)
Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: The 14-3-3σ case
Valentina Corradi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Fragment screening to predict druggability (ligandability) and lead discovery success
Fredrik N. B. Edfeldt et al.
DRUG DISCOVERY TODAY (2011)
Hippocampal dysregulation of synaptic plasticity-associated proteins with age-related cognitive decline
Heather D. VanGuilder et al.
NEUROBIOLOGY OF DISEASE (2011)
14-3-3theta Protects against Neurotoxicity in a Cellular Parkinson's Disease Model through Inhibition of the Apoptotic Factor Bax
Sunny R. Slone et al.
PLOS ONE (2011)
Discovery and structural characterization of a small molecule 14-3-3 protein-protein interaction inhibitor
Jing Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Identification and Structure of Small-Molecule Stabilizers of 14-3-3 Protein- Protein Interactions
Rolf Rose et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
Nicolas Dzamko et al.
BIOCHEMICAL JOURNAL (2010)
14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
R. Jeremy Nichols et al.
BIOCHEMICAL JOURNAL (2010)
Identification of the first non-peptidic small molecule inhibitor of the c-Abl/14-3-3 protein-protein interactions able to drive sensitive and Imatinib-resistant leukemia cells to apoptosis
Valentina Corradi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Aging alters the expression of neurotransmission-regulating proteins in the hippocampal synaptoproteome
Heather D. VanGuilder et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Tau oligomers and aggregation in Alzheimer's disease
Marco A. Meraz-Rios et al.
JOURNAL OF NEUROCHEMISTRY (2010)
DEGAS: De Novo Discovery of Dysregulated Pathways in Human Diseases
Igor Ulitsky et al.
PLOS ONE (2010)
Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease
T. A. Yacoubian et al.
CELL DEATH & DISEASE (2010)
A Structural Rationale for Selective Stabilization of Anti-tumor Interactions of 14-3-3 proteins by Cotylenin A
Christian Ottmann et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation
Golam Sadik et al.
JOURNAL OF NEUROCHEMISTRY (2009)
14-3-3 zeta and tau genes interactively decrease Alzheimer's disease risk
Ignacio Mateo et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2008)
Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein
Tilman Brummer et al.
EMBO JOURNAL (2008)
Gene-gene interaction between 14-3-3 zeta and butyrylcholinesterase modulates Alzheimer's disease risk
I. Mateo et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia
Masashi Ikeda et al.
HUMAN MOLECULAR GENETICS (2008)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Phosphorylation-independent interaction between 14-3-3 and exoenzyme S: from structure to pathogenesis
Christian Ottmann et al.
EMBO JOURNAL (2007)
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
Andrew B. West et al.
HUMAN MOLECULAR GENETICS (2007)
Kinase activity of mutant LRRK2 mediates neuronal toxicity
Wanli W. Smith et al.
NATURE NEUROSCIENCE (2006)
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Elisa Greggio et al.
NEUROBIOLOGY OF DISEASE (2006)
Intrinsic disorder is a key characteristic in partners that bind 14-3-3 proteins
DM Bustos et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)
Increased proliferation and altered growth factor dependence of human mammary epithelial cells overexpressing the Gab2 docking protein
T Brummer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
Role of 14-3-3γ in FE65-dependent gene transactivation mediated by the amyloid β-protein precursor cytoplasmic fragment
A Sumioka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Zeta 14-3-3 protein favours the formation of human tau fibrillar polymers
F Hernández et al.
NEUROSCIENCE LETTERS (2004)
Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection
LJ Lia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Phosphosite: A bioinformatics resource dedicated to physiological protein phosphorylation
PV Hornbeck et al.
PROTEOMICS (2004)
14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease
T Umahara et al.
ACTA NEUROPATHOLOGICA (2004)
Specification of 14-3-3 proteins in Lewy bodies
D Berg et al.
ANNALS OF NEUROLOGY (2003)
Specific 14-3-3 isoform detection and immunolocalization in prion diseases
HC Baxter et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2002)
14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains
Y Kawamoto et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
14-3-3 proteins mediate an essential anti-apoptotic signal
SC Masters et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
14-3-3ζ is an effector of tau protein phosphorylation
M Hashiguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
